Company profile for Compass Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Compass Therapeutics is a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and multispecific antibody therapeutics. Compass is leveraging its proprietary StitchMabsTM and common light-chain based multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. The comp...
Compass Therapeutics is a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and multispecific antibody therapeutics. Compass is leveraging its proprietary StitchMabsTM and common light-chain based multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. The company’s lead product candidate,

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/25/3194262/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-December-Investor-Events.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181347/0/en/Compass-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180398/0/en/Compass-Therapeutics-Presents-Preclinical-Data-on-CTX-10726-a-Differentiated-PD-1-x-VEGF-A-Bispecific-Antibody-at-the-40th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179225/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-November-Investor-Events.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/08/26/3139182/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-September-Investor-Events.html

GLOBENEWSWIRE
26 Aug 2025

https://www.globenewswire.com/news-release/2025/08/13/3132264/0/en/Compass-Therapeutics-Announces-Pricing-of-Upsized-120-Million-Public-Offering.html

GLOBENEWSWIRE
12 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty